Effect of orally administered guanosine on seizures and death induced by glutamatergic agents.
about
Guanosine: a Neuromodulator with Therapeutic Potential in Brain DisordersEnhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice.Mechanisms involved in the antinociception induced by systemic administration of guanosine in mice.A new device for step-down inhibitory avoidance task--effects of low and high frequency in a novel device for passive inhibitory avoidance task that avoids bioimpedance variationsGuanosine and its role in neuropathologies.Anti-aging effects of guanosine in glial cells.Intranasal guanosine administration presents a wide therapeutic time window to reduce brain damage induced by permanent ischemia in rats.Guanosine inhibits LPS-induced pro-inflammatory response and oxidative stress in hippocampal astrocytes through the heme oxygenase-1 pathway.Guanosine protects C6 astroglial cells against azide-induced oxidative damage: a putative role of heme oxygenase 1.Gliopreventive effects of guanosine against glucose deprivation in vitroGuanosine effect on cholesterol efflux and apolipoprotein E expression in astrocytes.Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptorsGuanosine prevents nitroxidative stress and recovers mitochondrial membrane potential disruption in hippocampal slices subjected to oxygen/glucose deprivation.Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder.Evidence that hyperprolinemia alters glutamatergic homeostasis in rat brain: neuroprotector effect of guanosine.Cooperation of non-effective concentration of glutamatergic system modulators and antioxidant against oxidative stress induced by quinolinic acid.Effects of chronic administered guanosine on behavioral parameters and brain glutamate uptake in rats.Effects of chronic guanosine treatment on hippocampal damage and cognitive impairment of rats submitted to chronic cerebral hypoperfusion.Neuroprotective effects of guanosine administration on behavioral, brain activity, neurochemical and redox parameters in a rat model of chronic hepatic encephalopathy.The modulatory effects of allopurinol on N-methyl D-aspartate receptors in the central nervous system.Guanosine promotes the up-regulation of inward rectifier potassium current mediated by Kir4.1 in cultured rat cortical astrocytes.Guanosine Anxiolytic-Like Effect Involves Adenosinergic and Glutamatergic Neurotransmitter Systems.Neuromodulatory Effects of Guanine-Based Purines in Health and Disease
P2860
Q28072158-3E333B25-ED00-4F91-BE6A-C2DCFB40101CQ30502426-75DE814F-8533-4D34-83BA-E58C7235B67FQ33767200-27D7D357-3B11-4F61-8B57-EA471D7FF76CQ35112594-BB02B697-F2C6-4571-B2BC-7EF5FD6F4D50Q37256409-7E606A9D-EF53-4DF4-94B4-718B973204C0Q37442075-C80C8C01-6ABA-49A7-B2AB-DB302D3BAAB6Q38358493-89B79D00-933A-47A2-B876-B2CD6840330CQ38830721-DB3C7614-768A-40B5-B83B-54647C5A91BCQ39011258-5CDB4110-F744-4645-BD6E-505B4078D6F8Q39126996-C09F96A2-AF09-4B91-93BD-97F69A104586Q40726571-A39072E2-FE2B-4EA9-A656-85589FCDADBFQ41422598-92DF43EE-78AE-46F2-BB0B-844B435E4D45Q42363254-54A594FE-896D-420F-A6E8-5AD58A2CA206Q42372900-4874259C-4003-430A-840C-DA922B8CC171Q44511068-30C75F91-9508-4C6B-8E5D-F8882772AE33Q44999577-C4E2A673-CDCF-40A4-A520-FC7D09DA7C6BQ45159502-1E3DAEC6-56C1-4FD6-8573-1655016DC0A1Q45325730-D0AB756F-A46B-4EB6-BD0C-044034C1F47CQ46899015-BA5105A3-5E1C-41E1-97CA-A3F5BA6C69E5Q48334442-24F86D9C-BD11-4880-A137-4BA3DCDAE26BQ48485531-5F23C4F0-AE9E-440A-BC9B-BF5ACCB47BBCQ49029414-D8643A90-58DE-4A0F-B7EF-D9381CD3DF0CQ59127756-3F1900E1-12DB-48C9-9615-2EBE444635AE
P2860
Effect of orally administered guanosine on seizures and death induced by glutamatergic agents.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Effect of orally administered ...... duced by glutamatergic agents.
@en
Effect of orally administered ...... duced by glutamatergic agents.
@nl
type
label
Effect of orally administered ...... duced by glutamatergic agents.
@en
Effect of orally administered ...... duced by glutamatergic agents.
@nl
prefLabel
Effect of orally administered ...... duced by glutamatergic agents.
@en
Effect of orally administered ...... duced by glutamatergic agents.
@nl
P2093
P50
P1433
P1476
Effect of orally administered ...... nduced by glutamatergic agents
@en
P2093
P304
P356
10.1016/S0006-8993(01)02734-2
P407
P577
2001-09-01T00:00:00Z